chr1:179293714:> Detail (hg38)
Information
Genome
| Assembly | Position |
|---|---|
| hg19 | chr1:179,262,849-179,327,815 |
| hg38 | chr1:179,293,714-179,358,680 |
HGVS
| Type | Transcript | Protein |
|---|---|---|
Summary
MGeND
| Clinical significance | |
| Variant entry | |
| GWAS entry | |
| Disease area statistics | Show details |
Frequency
[No Data.]
Prediction
[No Data.]
ClinVar
| Clinical Significance | |
| Review star | [No Data.] |
| Show details | |
Links
Disease area statistics
[No Data.]
MGeND
[No Data.]
ClinVar
[No Data.]
CIViC
[No Data.]
DisGeNET
| Score | Disease name | Description | Source | Pubmed | Links |
|---|---|---|---|---|---|
| 0.003 | renal cell carcinoma | NA | LHGDN | Detail | |
| <0.001 | squamous cell carcinoma | They also mimic human SCCs by activation of therapeutically relevant pathways in... | BeFree | 24953650 | Detail |
| <0.001 | Cardiovascular Diseases | NA | BeFree | Detail | |
| <0.001 | cerebral infarction | NA | BeFree | Detail | |
| <0.001 | Malignant tumor of cervix | Cervical cancer is almost invariably associated with infection by human papillom... | BeFree | 25921106 | Detail |
| <0.001 | Crohn Disease | NA | BeFree | Detail | |
| <0.001 | Delirium | NA | BeFree | Detail | |
| <0.001 | Diabetes | NA | BeFree | Detail | |
| <0.001 | diabetes mellitus | NA | BeFree | Detail | |
| <0.001 | Diabetes Mellitus, Non-Insulin-Dependent | We report four novel genes associated with type 2 diabetes and recovery upon wei... | BeFree | 25099943 | Detail |
| <0.001 | Down syndrome | NA | BeFree | Detail | |
| <0.001 | Dry Eye Syndromes | NA | BeFree | Detail | |
| <0.001 | Fanconi anemia | NA | BeFree | Detail | |
| <0.001 | giardiasis | NA | BeFree | Detail | |
| <0.001 | glioblastoma | We, therefore, treated a panel of established glioma cell lines, including EGFR ... | BeFree | 25482928 | Detail |
| 0.002 | Myeloproliferative disease | As JAK2 V617F, MPL W515L is a novel acquired mutation that induces constitutive ... | BeFree | 18464114 | Detail |
| <0.001 | Hematological Disease | NA | BeFree | Detail | |
| <0.001 | hepatitis C | NA | BeFree | Detail | |
| 0.002 | HIV Infections | NA | BeFree | Detail | |
| <0.001 | Hodgkin Disease | NA | BeFree | Detail | |
| 0.003 | Hyperlipidemia | NA | BeFree,GAD | Detail | |
| <0.001 | Immunologic Deficiency Syndromes | Normal viral infection of the midgut requires bacterial flora and is inhibited b... | BeFree | 25548172 | Detail |
| <0.001 | Immune System Diseases | NA | BeFree | Detail | |
| <0.001 | influenza | NA | BeFree | Detail | |
| <0.001 | Kidney Diseases | NA | BeFree | Detail | |
| <0.001 | leishmaniasis | Whereas JAK-STAT and TGF-β signalling pathways were more highly enriched using t... | BeFree | 25376316 | Detail |
| 0.002 | leukemia | NA | BeFree | Detail | |
| <0.001 | Acute lymphocytic leukemia | NA | BeFree | Detail | |
| <0.001 | Leukemia, Lymphocytic, Acute, L1 | Cellular phosphoprotein analysis demonstrated that JAK-mutated xenografts exhibi... | BeFree | 25504635 | Detail |
| <0.001 | Leukemia, Lymphocytic, Acute, L1 | These efforts have characterized the genetic basis of recently described and poo... | BeFree | 25696852 | Detail |
| 0.002 | Leukemia, Myelocytic, Acute | NA | BeFree | Detail | |
| <0.001 | myeloid leukemia | NA | BeFree | Detail | |
| <0.001 | Myeloid Leukemia, Chronic | NA | BeFree | Detail | |
| <0.001 | chronic neutrophilic leukemia | Laboratory studies revealed that CSF3RT618I induced JAK inhibitor-sensitive acti... | BeFree | 25575036 | Detail |
| <0.001 | acute promyelocytic leukemia | NA | BeFree | Detail | |
| <0.001 | Leukemia, T-Cell | NA | BeFree | Detail | |
| 0.001 | Adult T-Cell Lymphoma/Leukemia | NA | BeFree | Detail | |
| <0.001 | Leukoencephalopathy, Progressive Multifocal | NA | BeFree | Detail | |
| <0.001 | Liver neoplasms | NA | BeFree | Detail | |
| 0.002 | lymphoma | NA | BeFree | Detail | |
| <0.001 | Lymphoma, Non-Hodgkin | NA | BeFree | Detail | |
| 0.001 | melanoma | Here, we analyze the dysregulation of the Janus kinase (JAK)/STAT pathway and it... | BeFree | 25690042 | Detail |
| <0.001 | meningioma | NA | BeFree | Detail | |
| 0.001 | multiple myeloma | NA | BeFree | Detail | |
| <0.001 | myelofibrosis | Agents targeting the JAK-STAT pathway have dominated the investigational therape... | BeFree | 25189730 | Detail |
| 0.002 | Myeloproliferative disease | Furthermore, several classes of epigenetic modifiers have also been identified, ... | BeFree | 24445766 | Detail |
| 0.002 | Myeloproliferative disease | While JAK-STAT pathway activation has been shown to be central to the pathogenes... | BeFree | 25696868 | Detail |
| <0.001 | Neoplasm Metastasis | NA | BeFree | Detail | |
| <0.001 | nephroblastoma | NA | BeFree | Detail | |
| <0.001 | plasmacytoma | NA | BeFree | Detail | |
| <0.001 | polycythemia | NA | BeFree | Detail | |
| <0.001 | polycythemia vera | NA | BeFree | Detail | |
| <0.001 | psoriasis | NA | BeFree | Detail | |
| <0.001 | Rabies (disorder) | NA | BeFree | Detail | |
| <0.001 | rheumatic heart disease | Signal transducers and activators of transcription (STATs) gene polymorphisms re... | BeFree | 24797343 | Detail |
| <0.001 | sarcoidosis | NA | BeFree | Detail | |
| <0.001 | Staphylococcal Infections | NA | BeFree | Detail | |
| <0.001 | synovitis | NA | BeFree | Detail | |
| <0.001 | Thrombocythemia, Essential | NA | BeFree | Detail | |
| <0.001 | Vascular Diseases | NA | BeFree | Detail | |
| <0.001 | xanthomatosis | NA | BeFree | Detail | |
| <0.001 | B-Cell Lymphomas | NA | BeFree | Detail | |
| <0.001 | diffuse large B-cell lymphoma | The results of this study provide a rationale for the ongoing successful clinica... | BeFree | 25124685 | Detail |
| <0.001 | Lymphoma, T-Cell, Cutaneous | NA | BeFree | Detail | |
| <0.001 | severe combined immunodeficiency | NA | BeFree | Detail | |
| <0.001 | acute leukemia | NA | BeFree | Detail | |
| <0.001 | Pancreatitis, Chronic | NA | BeFree | Detail | |
| <0.001 | Epstein-Barr Virus Infections | NA | BeFree | Detail | |
| <0.001 | Primary Sj�gren's syndrome | The present aim was to investigate the activation status of different STAT prote... | BeFree | 25736842 | Detail |
| <0.001 | porphyria cutanea tarda | NA | BeFree | Detail | |
| 0.001 | Tumor Progression | NA | BeFree | Detail | |
| <0.001 | hepatoblastoma | NA | BeFree | Detail | |
| <0.001 | pancreatic carcinoma | NA | BeFree | Detail | |
| <0.001 | Female Pseudohermaphroditism | NA | BeFree | Detail | |
| <0.001 | Medullary carcinoma of thyroid | NA | BeFree | Detail | |
| <0.001 | Fibrosis, Liver | Acyl-CoA:cholesterol acyltransferase 1 mediates liver fibrosis by regulating fre... | BeFree | 24657401 | Detail |
| <0.001 | Malignant neoplasm of lung | NA | BeFree | Detail | |
| <0.001 | Cancer of Head and Neck | NA | BeFree | Detail | |
| <0.001 | T-cell adult acute lymphoblastic leukemia | A frequently affected pathway was the JAK/STAT pathway (18%) and a significant p... | BeFree | 25595890 | Detail |
| <0.001 | gallbladder adenocarcinoma | NA | BeFree | Detail | |
| <0.001 | Solid tumour | NA | BeFree | Detail | |
| <0.001 | cervix carcinoma | Cervical cancer is almost invariably associated with infection by human papillom... | BeFree | 25921106 | Detail |
| <0.001 | Dryness of eye | NA | BeFree | Detail | |
| <0.001 | Tumor necrosis | To this end, we identified TNBC-driven molecular pathways such as the Janus kina... | BeFree | 25611337 | Detail |
| <0.001 | Impaired cognition | NA | BeFree | Detail | |
| <0.001 | Glaucoma, Primary Open Angle | NA | BeFree | Detail | |
| <0.001 | eosinophilic esophagitis | NA | BeFree | Detail | |
| <0.001 | Breast Cancer, Familial | NA | BeFree | Detail | |
| <0.001 | Malignant neoplasm of pancreas | NA | BeFree | Detail | |
| <0.001 | juvenile myelomonocytic leukemia | NA | BeFree | Detail | |
| <0.001 | Respiratory syncytial virus (RSV) infection in conditions classified elsewhere and of unspecified site | NA | BeFree | Detail | |
| 0.001 | Malignant neoplasm of prostate | MAPK and JAK/STAT pathways targeted by miR-23a and miR-23b in prostate cancer: c... | BeFree | 25604141 | Detail |
| <0.001 | Primary immune deficiency disorder | NA | BeFree | Detail | |
| <0.001 | endometrial carcinoma | NA | BeFree | Detail | |
| <0.001 | Peritoneal Fibrosis | Pathway analysis showed that the Jak-STAT, TGF-beta and MAPK signaling pathways ... | BeFree | 25827714 | Detail |
| <0.001 | Thyroid carcinoma | NA | BeFree | Detail | |
| <0.001 | Malignant glioma | Genetic inhibition of Aurora kinase A or Aurora kinase B or survivin by RNA inte... | BeFree | 25482928 | Detail |
| 0.005 | Carcinogenesis | NA | BeFree | Detail | |
| <0.001 | Leukemogenesis | NA | BeFree | Detail | |
| <0.001 | Tumor Initiation | NA | BeFree | Detail | |
| 0.002 | prostate carcinoma | MAPK and JAK/STAT pathways targeted by miR-23a and miR-23b in prostate cancer: c... | BeFree | 25604141 | Detail |
| 0.002 | breast carcinoma | CYT387 treatment inhibited activation of both NF-κB and STAT and disrupted expre... | BeFree | 25365225 | Detail |
| 0.001 | Carcinoma of lung | NA | BeFree | Detail | |
| <0.001 | colon carcinoma | The CHIEF pathway was statistically significant for colon cancer (P(ARTP)= 0.03)... | BeFree | 25330801 | Detail |
| <0.001 | colon carcinoma | The JAK/STAT/SOC was significant for colon cancer survival (PARTP = 0.035). | BeFree | 25541970 | Detail |
| <0.001 | Mitochondrial Diseases | Modulating JAK-STAT activity may represent a novel therapeutic avenue for mitoch... | BeFree | 26122121 | Detail |
| <0.001 | Stuve-Wiedemann syndrome | NA | BeFree | Detail | |
| <0.001 | Rhabdoid Tumor of the Kidney | NA | BeFree | Detail | |
| <0.001 | Cerebral Ischemia | NA | BeFree | Detail | |
| <0.001 | Metastatic Prostate Carcinoma | NA | BeFree | Detail | |
| <0.001 | Squamous cell carcinoma of the head and neck | These discoveries correlate strongly with previous findings connecting STATs, NF... | BeFree | 25857630 | Detail |
| 0.001 | Chronic myeloproliferative disorder | Furthermore, several classes of epigenetic modifiers have also been identified, ... | BeFree | 24445766 | Detail |
| 0.001 | Chronic myeloproliferative disorder | While JAK-STAT pathway activation has been shown to be central to the pathogenes... | BeFree | 25696868 | Detail |
| <0.001 | Classical Hodgkin's Lymphoma | NA | BeFree | Detail | |
| <0.001 | Epithelioma | NA | BeFree | Detail | |
| 0.001 | Hepatocarcinogenesis | NA | BeFree | Detail | |
| <0.001 | Leukemia, Large Granular Lymphocytic | NA | BeFree | Detail | |
| <0.001 | Erythrocytosis | NA | BeFree | Detail | |
| <0.001 | Deficiency of acetyl-CoA acetyltransferase | NA | BeFree | Detail | |
| <0.001 | Meningioma, benign, no ICD-O subtype | NA | BeFree | Detail | |
| <0.001 | uterine corpus cancer | NA | BeFree | Detail | |
| 0.002 | liver carcinoma | We also found that inhibition of SPTBN1 or SMAD3 upregulated STAT3 promoter acti... | BeFree | 25096061 | Detail |
| <0.001 | Promyelocytic leukemia | NA | BeFree | Detail | |
| <0.001 | Nasopharyngeal carcinoma | NA | BeFree | Detail | |
| <0.001 | FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder) | NA | BeFree | Detail | |
| <0.001 | Triple Negative Breast Neoplasms | Here, we found that inducible IκB kinase-related (IKK-related) kinase IKBKE expr... | BeFree | 25365225 | Detail |
| <0.001 | Triple Negative Breast Neoplasms | To this end, we identified TNBC-driven molecular pathways such as the Janus kina... | BeFree | 25611337 | Detail |
| <0.001 | Experimental Organism Basal Cell Carcinoma | NA | BeFree | Detail | |
| <0.001 | Primary myelofibrosis | Agents targeting the JAK-STAT pathway have dominated the investigational therape... | BeFree | 25189730 | Detail |
| 0.010 | Alzheimer's disease | NA | BeFree,GAD,LHGDN | Detail | |
| <0.001 | anemia | NA | BeFree | Detail | |
| 0.003 | Anoxia | NA | LHGDN | Detail | |
| 0.002 | arteriosclerosis | NA | BeFree | Detail | |
| <0.001 | arthritis | NA | BeFree | Detail | |
| 0.001 | rheumatoid arthritis | This is the first study to provide evidence of a functional link between HIF1α, ... | BeFree | 24525913 | Detail |
| 0.001 | rheumatoid arthritis | Considering the interplay of multiple STATs in response to cytokines, we investi... | BeFree | 25847223 | Detail |
| <0.001 | ataxia telangiectasia | NA | BeFree | Detail | |
| 0.002 | atherosclerosis | NA | BeFree | Detail | |
| <0.001 | autistic disorder | The effects of sera from autistic children were rescued by pre-treatment with a ... | BeFree | 25769033 | Detail |
| <0.001 | Autoimmune Diseases | Network and protein-interaction analyses demonstrated converging roles for the s... | BeFree | 26301688 | Detail |
| <0.001 | Behcet Syndrome | Activation of the JAK/STAT pathway in Behcet's disease. | BeFree | 25410656 | Detail |
| <0.001 | Bone Diseases | NA | BeFree | Detail | |
| <0.001 | Brain Neoplasms | NA | BeFree | Detail | |
| 0.002 | Malignant neoplasm of breast | CYT387 treatment inhibited activation of both NF-κB and STAT and disrupted expre... | BeFree | 25365225 | Detail |
| <0.001 | Malignant tumor of colon | The CHIEF pathway was statistically significant for colon cancer (P(ARTP)= 0.03)... | BeFree | 25330801 | Detail |
| <0.001 | Malignant tumor of colon | The JAK/STAT/SOC was significant for colon cancer survival (PARTP = 0.035). | BeFree | 25541970 | Detail |
| <0.001 | Malignant neoplasm of endometrium | NA | BeFree | Detail | |
| <0.001 | Malignant neoplasm of thyroid | NA | BeFree | Detail | |
| <0.001 | Non-small cell lung carcinoma | NA | BeFree | Detail |
Annotation
Annotations
| Descrption | Source | Links |
|---|---|---|
| NA | DisGeNET | Detail |
| They also mimic human SCCs by activation of therapeutically relevant pathways including STAT and mTO... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Cervical cancer is almost invariably associated with infection by human papillomavirus (HPV), and pr... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| We report four novel genes associated with type 2 diabetes and recovery upon weight loss: ACAT1 (enc... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| We, therefore, treated a panel of established glioma cell lines, including EGFR overexpressors, and ... | DisGeNET | Detail |
| As JAK2 V617F, MPL W515L is a novel acquired mutation that induces constitutive cytokine-independent... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Normal viral infection of the midgut requires bacterial flora and is inhibited by the activities of ... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Whereas JAK-STAT and TGF-β signalling pathways were more highly enriched using targets of miRNAs upr... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Cellular phosphoprotein analysis demonstrated that JAK-mutated xenografts exhibited heightened activ... | DisGeNET | Detail |
| These efforts have characterized the genetic basis of recently described and poorly understood subty... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Laboratory studies revealed that CSF3RT618I induced JAK inhibitor-sensitive activation of JAK-STAT a... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Here, we analyze the dysregulation of the Janus kinase (JAK)/STAT pathway and its role in the suppre... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Agents targeting the JAK-STAT pathway have dominated the investigational therapeutic portfolio over ... | DisGeNET | Detail |
| Furthermore, several classes of epigenetic modifiers have also been identified, in patients with MPN... | DisGeNET | Detail |
| While JAK-STAT pathway activation has been shown to be central to the pathogenesis of the MPN phenot... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Signal transducers and activators of transcription (STATs) gene polymorphisms related with susceptib... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| The results of this study provide a rationale for the ongoing successful clinical trials targeting t... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| The present aim was to investigate the activation status of different STAT proteins in peripheral bl... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Acyl-CoA:cholesterol acyltransferase 1 mediates liver fibrosis by regulating free cholesterol accumu... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| A frequently affected pathway was the JAK/STAT pathway (18%) and a significant proportion of T-ALL p... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Cervical cancer is almost invariably associated with infection by human papillomavirus (HPV), and pr... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| To this end, we identified TNBC-driven molecular pathways such as the Janus kinase-signal transducer... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| MAPK and JAK/STAT pathways targeted by miR-23a and miR-23b in prostate cancer: computational and in ... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Pathway analysis showed that the Jak-STAT, TGF-beta and MAPK signaling pathways had a close relation... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Genetic inhibition of Aurora kinase A or Aurora kinase B or survivin by RNA interference also sensit... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| MAPK and JAK/STAT pathways targeted by miR-23a and miR-23b in prostate cancer: computational and in ... | DisGeNET | Detail |
| CYT387 treatment inhibited activation of both NF-κB and STAT and disrupted expression of the protumo... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| The CHIEF pathway was statistically significant for colon cancer (P(ARTP)= 0.03) with the most signi... | DisGeNET | Detail |
| The JAK/STAT/SOC was significant for colon cancer survival (PARTP = 0.035). | DisGeNET | Detail |
| Modulating JAK-STAT activity may represent a novel therapeutic avenue for mitochondrial diseases, wh... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| These discoveries correlate strongly with previous findings connecting STATs, NF-κB and AP1 in HNSCC... | DisGeNET | Detail |
| Furthermore, several classes of epigenetic modifiers have also been identified, in patients with MPN... | DisGeNET | Detail |
| While JAK-STAT pathway activation has been shown to be central to the pathogenesis of the MPN phenot... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| We also found that inhibition of SPTBN1 or SMAD3 upregulated STAT3 promoter activity in HCC cell-lin... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Here, we found that inducible IκB kinase-related (IKK-related) kinase IKBKE expression and JAK/STAT ... | DisGeNET | Detail |
| To this end, we identified TNBC-driven molecular pathways such as the Janus kinase-signal transducer... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Agents targeting the JAK-STAT pathway have dominated the investigational therapeutic portfolio over ... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| This is the first study to provide evidence of a functional link between HIF1α, STAT3 and Notch-1 si... | DisGeNET | Detail |
| Considering the interplay of multiple STATs in response to cytokines, we investigated how IL-6 and i... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| The effects of sera from autistic children were rescued by pre-treatment with a ciliary neurotrophic... | DisGeNET | Detail |
| Network and protein-interaction analyses demonstrated converging roles for the signaling pathways of... | DisGeNET | Detail |
| Activation of the JAK/STAT pathway in Behcet's disease. | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| CYT387 treatment inhibited activation of both NF-κB and STAT and disrupted expression of the protumo... | DisGeNET | Detail |
| The CHIEF pathway was statistically significant for colon cancer (P(ARTP)= 0.03) with the most signi... | DisGeNET | Detail |
| The JAK/STAT/SOC was significant for colon cancer survival (PARTP = 0.035). | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
Overlapped Transcript Coordinates
| Gene | Transcript ID | Exon Number | Chromosome | Start | Stop | Type | Amino Mutation | Transcript Position | Links |
|---|
Overlapped Transcript
| Gene | Transcript ID | Chromosome | Start | Stop | Links |
|---|
- Gene
- -
- dbSNP
- rs386626619 dbSNP
- Genome
- hg38
- Position
- chr1:179,293,714-179,358,680
- Variant Type
- snv
Genome browser